Status:
ACTIVE_NOT_RECRUITING
Conduction System Pacing International Registry (CONSPIRE)
Lead Sponsor:
University of Chicago
Collaborating Sponsors:
Biotronik SE & Co. KG
Conditions:
Bradyarrhythmia
Heart Failure
Eligibility:
All Genders
18+ years
Brief Summary
The purpose of this registry study is to collect information about routine clinical practices with device implantation to treat bradycardia and cardiac systolic dysfunction (heart rhythm disorders) ac...
Detailed Description
During this past decade, there has been a dramatic surge in interest in new physiologic pacing strategies which engage and take advantage of the intrinsic cardiac conduction system. These approaches i...
Eligibility Criteria
Inclusion
- Meets American College of Cardiology (ACC)/American Heart Association (AHA)/Heart Rhythm Society (HRS) guidelines for bradycardia, or
- Meets ACC/AHA/HRS guidelines for cardiac resynchronization therapy (CRT).
Exclusion
- Age \< 18 years
- Inability of patient capacity to provide consent for themselves either due to medical or psychiatric comorbidity
- Pregnancy
- Difficulty with follow-up
Key Trial Info
Start Date :
April 4 2021
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
February 1 2026
Estimated Enrollment :
383 Patients enrolled
Trial Details
Trial ID
NCT04831125
Start Date
April 4 2021
End Date
February 1 2026
Last Update
February 18 2025
Active Locations (8)
Enter a location and click search to find clinical trials sorted by distance.
1
University of Arizona
Tucson, Arizona, United States, 85719
2
University of Chicago
Chicago, Illinois, United States, 60637
3
Icahn School of Medicine at Mount Sinai & Mount Sinai Hospital
New York, New York, United States, 10029
4
University of Pennsylvania
Philadelphia, Pennsylvania, United States, 19104